NaTure CHemisTry
Articles
15. Vallejo, D., Nikoomanzar, A., Paegel, B. M. & Chaput, J. C.
Fluorescence-activated droplet sorting for single-cell directed evolution. ACS
Synth. Biol. 8, 1430–1440 (2019).
46. France, S. P. et al. Identifcation of novel bacterial members of the imine
reductase enzyme family that perform reductive amination. ChemCatChem
10, 510–514 (2018).
47. Gheorghe‐Doru, R. et al. Efcient biocatalytic reductive aminations by
extending the imine reductase toolbox. ChemCatChem 9, 4475–4479 (2017).
48. Zhu, J. et al. Enantioselective synthesis of 1-aryl-substituted tetrahydroiso-
quinolines employing imine reductase. ACS Catal. 7, 7003–7007 (2017).
49. Li, H., Luan, Z. J., Zheng, G. W. & Xu, J. H. Efcient synthesis of chiral
indolines using an imine reductase from Paenibacillus lactis. Adv. Synth.
Catal. 357, 1692–1696 (2015).
50. Nugent, T. C. & El‐Shazly, M. Chiral amine synthesis—recent developments
and trends for enamide reduction, reductive amination, and imine reduction.
Adv. Synth. Catal. 352, 753–819 (2010).
51. Baud, D., Jefries, J. W. E., Moody, T. S., Ward, J. M. & Hailes, H. C. A
metagenomics approach for new biocatalyst discovery: application to
transaminases and the synthesis of allylic amines. Green Chem. 19,
1134–1143 (2017).
52. Hernández, K., Szekrenyi, A. & Clapés, P. Nucleophile promiscuity of natural
and engineered aldolases. ChemBioChem 19, 1353–1358 (2018).
53. Leipold, L. et al. Te identifcation and use of robust transaminases from a
domestic drain metagenome. Green Chem. 21, 75–86 (2019).
54. Caparco, A. et al. Metagenomic mining for amine dehydrogenase discovery.
Adv. Synth. Catal. 362, 2427 (2020).
55. Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable
Sharing of Benefts Arising from their Utilization to the Convention on
Biological Diversity Treaty (UK Parliament Foreign And Commonwealth
Ofce, 2010).
56. Zawodny, W. et al. Chemoenzymatic synthesis of substituted azepanes by
sequential biocatalytic reduction and organolithium-mediated rearrangement.
J. Am. Chem. Sci. 140, 17872–17877 (2018).
57. Montgomery, S. L. et al. Characterization of imine reductases in reductive
amination for the exploration of structure–activity relationships. Sci. Adv. 6,
eaay9320 (2020).
16. Gielen, F. et al. Ultrahigh-throughput-directed enzyme evolution by
absorbance-activated droplet sorting (AADS). Proc. Natl Acad. Sci. USA 113,
E7383–E7389 (2016).
17. Davids, T., Schmidt, M., Böttcher, D. & Bornscheuer, U. T. Strategies for the
discovery and engineering of enzymes for biocatalysis. Curr. Opin. Chem.
Biol. 17, 215–220 (2013).
18. Bunzel, H. A., Garrabou, X., Pott, M. & Hilvert, D. Speeding up enzyme
discovery and engineering with ultrahigh-throughput methods. Curr. Opin.
Struct. Biol. 48, 149–156 (2018).
19. Ghislieri, D. & Turner, N. J. Biocatalytic approaches to the synthesis of
enantiomerically pure chiral amines. Top. Catal. 57, 284–300 (2014).
20. Weise, N., Parmeggiani, F., Ahmed, S. & Turner, N. J. Discovery and
investigation of mutase-like activity in a phenylalanine ammonia lyase from
Anabaena variabilis. Top. Catal. 61, 288–295 (2018).
21. Grogan, G. Synthesis of chiral amines using redox biocatalysis. Curr. Opin.
Chem. Biol. 43, 15–22 (2018).
22. Turner, N. J. Enantioselective oxidation of C–O and C–N bonds using
oxidases. Chem. Rev. 111, 4073–4087 (2011).
23. Jia, Z.-J., Gao, S. & Arnold, F. H. Enzymatic primary amination of benzylic
and allylic C(sp3)-H bonds. J. Am. Chem. Soc. 142, 10279–10283 (2020).
24. Schrittwieser, J. H., Velikogne, S. & Kroutil, W. Biocatalytic imine
reduction and reductive amination of ketones. Adv. Synth. Catal. 357,
1665–1685 (2015).
25. Hyslop, J. F. et al. Biocatalytic synthesis of chiral N-functionalized amino
acids. Angew. Chem. Int. Ed. 57, 13821–13824 (2018).
26. Stahl, L. Te Handbook of Homogeneous Hydrogenation, Volumes 1−3
Edited by Johannes G. de Vries (DSM Pharmaceutical Products, Geleen,
Te Netherlands) and Cornelis J. Elsevier (Universiteit van Amsterdam, Te
Netherlands). Wiley-VCH Verlag GmbH & Co. KGaA:Weinheim. 2007.
1632 pp. $625.00. ISBN 978-3-527-31161-3. J. Am. Chem. Soc. 129,
10297–10298 (2007).
27. Li, W. Stereoselective Formation of Amines (Springer, 2014).
28. Roughley, S. D. & Jordan, A. M. Te medicinal chemist’s toolbox: an analysis
of reactions used in the pursuit of drug candidates. J. Med. Chem. 54,
3451–3479 (2011).
29. Wang, L. & Xiao, J. Hydrogen-atom transfer reactions. Top. Curr. Chem. 374,
1–55 (2016).
30. Hou, G. et al. Enantioselective hydrogenation of N–H imines. J. Am. Chem.
Soc. 131, 9882–9883 (2009).
58. Mayer, K. M. & Arnold, F. H. A colorimetric assay to quantify dehydrogenase
activity in crude cell lysates. J. Biomol. Screen 7, 135–140 (2002).
59. Peng, H. et al. Deciphering piperidine formation in polyketide-derived
indolizidines reveals a thioester reduction, transamination, and unusual imine
reduction process. ACS Chem. Biol. 11, 3278–3283 (2016).
60. Ye, S. et al. Identifcation by genome mining of a type I polyketide gene
cluster from Streptomyces argillaceus involved in the biosynthesis of pyridine
and piperidine alkaloids argimycins P. Front. Microbiol. 8, 194 (2017).
61. Lenz, M. et al. Asymmetric ketone reduction by imine reductases.
ChemBioChem 18, 253–256 (2017).
31. Aurelio, L., Brownlee, R. & Hughes, A. B. Synthetic preparation of
N-methyl-ɑ-amino acids. Chem. Rev. 104, 5823–5846 (2004).
32. Aleku, A. G. et al. A reductive aminase from Aspergillus oryzae. Nat. Chem. 9,
961–969 (2017).
62. González-Martínez, D. et al. Asymmetric synthesis of primary and secondary
β-fuoro-arylamines using reductive aminases from fungi. ChemCatChem 12,
2421 (2020).
63. Smith, J. A. et al. in A101 Advances in Cough, Dyspnea, and Interventional
Pulmonary A2672–A2672 (American Toracic Society, 2017).
64. Darcsi, A., Tóth, G., Kökösi, J. & Béni, S. Structure elucidation of a process-
related impurity of dapoxetine. J. Pharm. Biomed. Anal. 96, 272–277 (2014).
65. Fuchs, M., Koszelewski, D., Tauber, K., Kroutil, W. & Faber, K.
Chemoenzymatic asymmetric total synthesis of (S)-rivastigmine using
omega-transaminases. Chemic. Commun. 46, 5500–5502 (2010).
66. Zhang, D. et al. Development of β-amino acid dehydrogenase for the
synthesis of β-amino acids via reductive amination of β-keto acids. ACS
Catal. 5, 2220–2224 (2015).
33. Tobias, H. et al. Direct reductive amination of ketones: structure and activity
of S‐selective imine reductases from Streptomyces. ChemCatChem 6,
2248–2252 (2014).
34. Scheller, P. N., Lenz, M., Hammer, S. C., Hauer, B. & Nestl, B. M. Imine
reductase‐catalyzed intermolecular reductive amination of aldehydes and
ketones. ChemCatChem 7, 3239–3242 (2015).
35. Wetzl, D. et al. Asymmetric reductive amination of ketones catalyzed by
imine reductases. ChemCatChem 8, 2023–2026 (2016).
36. Maugeri, Z. & Rother, D. Reductive amination of ketones catalyzed by whole
cell biocatalysts containing imine reductases (IREDs). J. Biotechnol. 258,
167–170 (2017).
67. Midelfort, K. et al. Redesigning and characterizing the substrate specifcity
and activity of Vibrio fuvialis aminotransferase for the synthesis of
imagabalin. Protein Eng. Des. Sel. 26, 25–33 (2013).
37. Roiban, G. D. et al. Efcient biocatalytic reductive aminations by extending
the imine reductase toolbox. ChemCatChem 9, 4475–4479 (2017).
38. Sharma, M. et al. A mechanism for reductive amination catalyzed by fungal
reductive aminases. ACS Catal. 8, 11534–11541 (2018).
39. Mitsukura, K., Suzuki, M., Tada, K., Yoshida, T. & Nagasawa, T. Asymmetric
synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell
catalyst of enantioselective imine reductase. Org. Biomol. Chem. 8,
4533–4535 (2010).
68. Juraisti, E. & Soloshonok, V. Enantioselective Synthesis of β-Amino Acids 2nd
edn (Wiley, 2005).
69. Iglesias, E. Ester hydrolysis and enol nitrosation reactions of ethyl
cyclohexanone-2-carboxylate inhibited by β-cyclodextrin. J. Org. Chem. 65,
6583–6594 (2000).
70. Bornadel, A. et al. Technical considerations for scale-up of
imine-reductase-catalyzed reductive amination: a case study. Org Process. Res.
Dev. 23, 1262–1268 (2019).
40. Mitsukura, K. et al. Purifcation and characterization of a novel (R)-imine
reductase from Streptomyces sp. GF3587. Biosci. Biotechnol. Biochem. 75,
1778–1782 (2011).
71. Mangas-Sanchez, J. et al. Asymmetric synthesis of primary amines catalyzed
by fungal reductive aminases. Chem. Sci. 11, 5052–5057 (2020).
72. Sutin, L. et al. Oxazolones as potent inhibitors of 11β-hydroxysteroid
dehydrogenase type 1. Bioorg. Med. Chem. Lett. 17, 4837–4840 (2007).
73. Afanasyev, O. I., Kuchuk, E., Usanov, D. L. & Chusov, D. Reductive amination
in the synthesis of pharmaceuticals. Chem. Rev. 119, 11857–11911 (2019).
74. Salzmann, T. N., Ratclife, R. W., Christensen, B. G. & Boufard, F. A. A
stereocontrolled synthesis of (+)-thienamycin. J. Am. Chem. Sci. 102,
6161–6163 (1980).
41. Slabu, I., Galman, J. L., Lloyd, R. C. & Turner, N. J. Discovery, engineering,
and synthetic application of transaminase biocatalysts. ACS Catal. 7,
8263–8284 (2017).
42. Mangas-Sanchez, J. et al. Imine reductases (IREDs). Curr. Opin. Chem. Biol.
37, 19–25 (2017).
43. Lenz, M., Borlinghaus, N., Weinmann, L. & Nestl, B. M. Recent advances in
imine reductase-catalyzed reactions. World J. Microbiol. Biotechnol. 33, 199
(2017).
44. Schober, M. et al. Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by
directed evolution of an imine reductase. Nat. Catal. 2, 909–915 (2019).
45. Wetzl, D. et al. Expanding the imine reductase toolbox by exploring the
bacterial protein‐sequence space. ChemBioChem 16, 1749–1756 (2015).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
© The Author(s), under exclusive licence to Springer Nature Limited 2020
148